查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085383

醫藥臨床實驗室耗材及物流市場：依服務、階段、運輸方式、溫度範圍、包裝類型、分子類型、治療應用及最終用戶分類－2026-2032年全球市場預測

Clinical Trial Supply & Logistics for Pharmaceutical Market by Service, Phase, Transportation Mode, Temperature Range, Packaging Type, Molecule Type, Therapeutic Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫藥臨床試驗用品和物流市場將成長至 37.9 億美元，複合年成長率為 7.81%。

主要市場統計數據
基準年 2025 22.4億美元
預計年份：2026年 24.1億美元
預測年份：2032年 37.9億美元
複合年成長率 (%) 7.81%

藥品臨床實驗室用品和物流執行摘要

隨著臨床試驗的範圍不斷擴大，突破地域、治療領域和患者群體的限制，藥物臨床試驗用品和物流正成為製藥公司、生物技術公司和合約研究組織 (CRO) 的戰略驅動力。如今，這項職能涵蓋了臨床實驗藥物規劃、對照藥物採購、包裝和標籤、低溫運輸物流、倉庫網路、海關協調、退貨、核對和處置等各個方面。

臨床實驗室供應環境的變革性變化

臨床實驗室的供應環境正從被動的、響應式的運輸模式轉向主動的、數據主導協調模式。隨著混合式和分散式檢測模式的普及，對直接送達患者、家庭醫療保健協調、患者專用試劑盒、現場護理支援以及由檢驗的即時供應管理系統（RTSM）和整合即時供應管理系統（IRT）支援的靈活補給模式的需求日益成長。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在臨床實驗室供應計劃、物流執行和品質監控的各個領域創造累積價值。 AI 驅動的需求預測透過分析病患入組率、實驗室運作時間表、病患就診時間表、方案變更、配藥規則和歷史消耗模式，改善需求計劃，幫助申辦方減少缺貨、避免過期風險並最大限度地減少過度生產。

全球臨床實驗室物流的關鍵區域洞察

北美地區憑藉其高度集中的申辦方、合約研究組織 (CRO)、專業倉庫、大學附屬醫院以及溫控配送網路，仍然是醫藥臨床試驗用品和物流的領先地區。美國和加拿大受益於成熟的監管流程、先進的數位基礎設施以及完善的專業藥房和宅配系統。同時，墨西哥作為鄰近的臨床研究和物流市場，其重要性日益凸顯，在區域受試者招募和跨境協調方面發揮越來越重要的作用。

針對特定群體的臨床實驗室供應鏈網路的關鍵見解

七國集團（G7）已發展成為成熟的臨床實驗室物資供應中心，擁有完善的監管機構、先進的低溫運輸能力、高品質的醫療保健體系，以及申辦方和合約研究組織（CRO）之間較高的外包率。歐盟透過統一的臨床實驗室法規和利用臨床技術資訊系統（CTIS）的申請流程，實現了規模化發展，但多語種標籤檢視、成員國要求、合格人員出貨核准以及跨境配送等方面仍需專家協調。

各國在策略性臨床實驗室實施上的關鍵見解。

美國是全球最大的藥品臨床試驗用品和物流中心，這得益於其廣泛的試驗活動、FDA的監管、專業的配送能力、學術研究網路以及先進的低溫運輸供應商。加拿大擁有高品質的臨床研究基礎設施、可預測的監管流程和可靠的溫控物流，而墨西哥則支援區域多元化、患者獲取和近岸供應策略。巴西是拉丁美洲最重要的臨床研究市場，除了擁有龐大的患者群體外，對可靠的進口、標籤檢視、倉儲服務和海關專業知識的需求也在不斷成長。

為行業領導者提供的實用建議

產業領導者應建構一個整合的臨床藥物供應鏈營運模式，將方案設計、受試者招募預測、生產計畫、包裝、標籤、藥物儲存庫規劃、研究藥物管理系統（RTSM）配置和物流執行等環節連結起來。從臨床實驗設計階段就讓供應鏈儘早介入，可以減少不必要的方案修改、庫存過剩、補貨延遲和研究中心層級的中斷。

調查方法

本調查方法結合了監管機構的二次調查、ICH 指南、世衛組織資源、GDP 框架、臨床實驗室註冊資訊、藥典標準、行業出版刊物、公司申報資料以及 IATA 溫度控制指南等物流標準。這些資訊來源為基於證據的評估提供了支持，評估內容涵蓋監管預期、供應鏈實踐、技術應用、品質要求和區域營運條件。

結論

藥物臨床試驗的耗材和物流正變得對試驗結果、病患取得和監管合規性至關重要。全球化檢測、分散式模式、生技藥品、細胞和基因療法、更嚴格的低溫運輸要求以及對複雜供應鏈即時可視性的日益成長的需求，正在重塑市場格局。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 醫藥市場：依服務類型分類

  • 臨床實驗藥物的包裝
  • 藥品標籤服務
  • 管制藥物的採購
  • 藥品儲存配送
  • 藥品低溫運輸運輸
  • 倉庫管理
  • 退貨和核實

第8章 醫藥市場：依階段分類

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第9章 藥品市場：依運輸方式分類

  • 空運貨物
    • 包機
    • 標準
  • 鐵路貨運
    • 直接地
    • 多式聯運
  • 陸上貨運
  • 海上運輸

第10章 醫藥市場：依溫度範圍分類

  • 室溫
  • 管制室溫
  • 冰凍
  • 冷藏

第11章 藥品市場：依包裝類型分類

  • 活性包裝
    • 低溫運輸容器
    • 冷凍機組
  • 混合包裝
    • 整合解決方案
    • 模組化系統
  • 被動式包裝
    • 冷藏箱
    • 保暖繃帶

第12章 醫藥市場：依分子類型分類

  • 小分子藥物
  • 生物製藥

第13章 醫藥市場：依治療應用分類

  • 腫瘤學
  • 神經病學
  • 循環系統
  • 感染疾病
  • 代謝性疾病
  • 呼吸系統疾病

第14章 醫藥市場：依最終用戶分類

  • 生技公司
  • 臨床檢測設施
  • 受託研究機構
  • 製藥公司
  • 第三方物流供應商

第15章 醫藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章 醫藥市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 藥品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Aenova Group GmbH
  • Almac Group
  • AmerisourceBergen Corporation
  • Bilcare Limited
  • Biocair International Limited
  • Catalent, Inc.
  • Clinigen Group PLC
  • DHL International GmbH（Deutsche Post AG）
  • Eurofins Scientific SE
  • FedEx Corporation
  • GBA Group AG
  • ICON PLC
  • Infosys Limited
  • KLIFO A/S
  • Lonza Group
  • Metrics Contract Services（Mayne Pharma group）
  • Movianto
  • Nuvisan GmbH
  • Parexel International Corporation
  • PCI Pharma Services
  • Pharm-Olam International Ltd.
  • Seveillar Clinical Trial Supplies Pvt. Ltd.
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific, Inc.
  • UDG Healthcare PLC
Product Code: MRR-4311CE1A33A9

The Clinical Trial Supply & Logistics for Pharmaceutical Market is projected to grow by USD 3.79 billion at a CAGR of 7.81% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.24 billion
Estimated Year [2026] USD 2.41 billion
Forecast Year [2032] USD 3.79 billion
CAGR (%) 7.81%

Clinical Trial Supply & Logistics Executive Summary

Clinical trial supply and logistics has become a strategic enabler for pharmaceutical, biotechnology, and contract research organizations as trials expand across geographies, therapeutic areas, and patient populations. The function now spans investigational medicinal product planning, comparator sourcing, packaging and labeling, cold chain logistics, depot networks, customs coordination, returns, reconciliation, and destruction.

Market momentum is supported by the globalization of clinical research, the rise of biologics and cell and gene therapies, increased use of decentralized clinical trials, and stricter expectations for temperature control and traceability. Sponsors are prioritizing resilient clinical trial supply chains that protect patient safety, reduce drug waste, maintain Good Distribution Practice compliance, and preserve investigational product integrity across every shipment lane.

Transformative Shifts in the Clinical Supply Landscape

The clinical trial supply landscape is shifting from reactive shipment execution to proactive, data-led supply orchestration. Hybrid and decentralized trial models are increasing demand for direct-to-patient delivery, home healthcare coordination, patient-specific kits, local nursing support, and flexible resupply models supported by validated RTSM and IRT systems.

At the same time, advanced therapies are reshaping cold chain logistics requirements. Biologics, vaccines, and cell and gene therapies often require controlled 2°C to 8°C, frozen, ultra-frozen, or cryogenic handling, making lane qualification, temperature-monitoring devices, validated packaging, and depot readiness essential. Regulatory frameworks such as ICH GCP, EU Clinical Trial Regulation, FDA requirements, and GDP guidance continue to elevate expectations for documentation, quality management, pharmacovigilance alignment, and end-to-end product accountability.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across clinical trial supply planning, logistics execution, and quality oversight. AI-enabled forecasting can improve demand planning by analyzing enrollment rates, site activation timelines, patient visit schedules, protocol amendments, dispensing rules, and historical consumption patterns, helping sponsors reduce stockouts, avoid expiry risk, and minimize overproduction.

AI is also improving risk sensing across shipment lanes, depot inventory, customs delays, weather disruption, carrier performance, and temperature excursion probability. When deployed within validated GxP environments, AI can support exception management, document review, predictive maintenance for cold chain assets, and automated alerts. However, industry adoption depends on data integrity, model validation, explainability, cybersecurity, audit trails, and human oversight aligned with 21 CFR Part 11 and global computer system validation expectations.

Key Regional Insights Across Global Trial Logistics

North America remains a leading region for clinical trial supply and logistics due to a high concentration of sponsors, CROs, specialty depots, academic medical centers, and temperature-controlled distribution networks. The United States and Canada benefit from mature regulatory pathways, advanced digital infrastructure, and well-established specialty pharmacy and courier capabilities, while Mexico is gaining importance as a nearshore clinical research and logistics market with growing relevance for regional enrollment and cross-border coordination.

Europe is shaped by the EU Clinical Trial Regulation, CTIS implementation, GDP standards, and strong cross-border trial activity across Germany, France, Italy, Spain, and the United Kingdom, making regulatory documentation, multilingual labeling, qualified person release, and depot coordination critical. Asia-Pacific continues to expand through China, India, Japan, South Korea, Australia, and ASEAN markets, supported by large patient pools, growing biotech investment, regulatory modernization, and improving clinical research infrastructure. Latin America, led by Brazil and Mexico, offers recruitment advantages and strong therapeutic-area diversity but requires robust customs planning, import licensing, local labeling control, and country-specific regulatory expertise. The Middle East, particularly GCC countries, is investing in healthcare infrastructure, specialty hospitals, and clinical research capabilities, while Africa is emerging selectively as sponsors address depot capacity, temperature control, ethics review timelines, import processes, and last-mile logistics resilience.

Key Group Insights for Clinical Trial Supply Networks

The G7 markets represent mature clinical trial supply hubs with established regulators, advanced cold chain capacity, high-quality healthcare systems, and high outsourcing penetration among sponsors and CROs. The European Union adds scale through harmonized clinical trial regulation and CTIS-enabled submission processes, although multilingual labeling, member-state requirements, qualified person release, and cross-border distribution still demand expert coordination.

BRICS countries are increasingly important for patient recruitment, pharmaceutical manufacturing, and regional depot expansion, with China, India, and Brazil standing out for large trial populations, growing domestic innovation, and expanding clinical research infrastructure. ASEAN markets are gaining attention as Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines improve healthcare research ecosystems, regional connectivity, and temperature-controlled logistics capabilities. The GCC is positioning itself as a premium healthcare and clinical research corridor, supported by hospital investment, regulatory modernization, and logistics infrastructure upgrades. NATO-aligned markets also influence resilience planning, cybersecurity standards, secure transport lanes, sanctions compliance, and contingency routing, which are increasingly relevant for high-value investigational products and advanced therapies.

Key Country Insights for Strategic Trial Execution

The United States is the largest operational anchor for clinical trial supply and logistics, supported by extensive trial activity, FDA oversight, specialty distribution capacity, academic research networks, and advanced cold chain providers. Canada offers high-quality clinical research infrastructure, predictable regulatory processes, and reliable temperature-controlled logistics, while Mexico supports regional diversification, patient access, and nearshore supply strategies. Brazil remains Latin America's most important clinical research market, combining large patient access with growing demand for reliable importation, labeling, depot services, and customs expertise.

In Europe, the United Kingdom maintains strong early-phase, oncology, vaccine, and specialty trial capabilities, while Germany and France are major pharmaceutical and biotech centers with robust GDP-compliant logistics infrastructure. Italy and Spain are important for oncology, rare disease, and hospital-based studies, supported by experienced investigators and established healthcare networks. Russia presents a more complex operating environment due to geopolitical, sanctions, payment, and logistics constraints, requiring careful feasibility, ethics, import, and compliance assessment before trial execution.

China and India are central to Asia-Pacific growth because of large patient populations, expanding domestic biopharma activity, broader hospital networks, and increasing regulatory modernization. Japan is a high-value market with strict quality expectations, mature clinical operations, and strong demand for compliant labeling and temperature assurance, while Australia is widely used for early-phase studies due to efficient clinical trial pathways, tax incentives, and strong hospital networks. South Korea continues to gain prominence through advanced healthcare infrastructure, oncology expertise, rapid site activation, and globally competitive trial sites.

Actionable Recommendations for Industry Leaders

Industry leaders should build integrated clinical supply operating models that connect protocol design, enrollment forecasting, manufacturing schedules, packaging, labeling, depot planning, RTSM configuration, and logistics execution. Early supply chain involvement in study design can reduce avoidable amendments, excess inventory, resupply delays, and site-level disruptions.

Sponsors and service providers should qualify temperature-controlled lanes, diversify depots and carriers, validate AI-enabled tools, and strengthen real-time visibility across inventory and shipments. Priority actions include robust comparator sourcing governance, direct-to-patient logistics SOPs, cybersecurity controls, sustainability metrics for packaging and transport, vendor risk management, and contingency planning for customs delays, geopolitical disruption, strikes, natural disasters, and temperature excursions.

Research Methodology

The research methodology combines secondary research from regulatory agencies, ICH guidance, WHO resources, GDP frameworks, clinical trial registries, pharmacopeial standards, industry publications, company filings, and logistics standards such as IATA temperature-control guidance. These sources support evidence-based assessment of regulatory expectations, supply chain practices, technology adoption, quality requirements, and regional operating conditions.

Primary validation is conducted through expert interviews and structured discussions with pharmaceutical sponsors, CROs, clinical supply managers, depot operators, specialty logistics providers, packaging vendors, quality leaders, and technology suppliers. Findings are triangulated across service type, trial phase, therapeutic area, temperature range, trial model, end user, and geography to provide a reliable view of clinical trial supply and logistics without relying on unsupported assumptions.

Conclusion

Clinical trial supply and logistics is moving to the center of trial performance, patient access, and regulatory compliance. The market is being reshaped by globalized studies, decentralized models, biologics, cell and gene therapies, stricter cold chain requirements, and increasing demand for real-time visibility across complex supply networks.

Organizations that invest in resilient cold chain logistics, validated digital platforms, AI-supported planning, regional expertise, and patient-centric delivery models will be better positioned to reduce risk and accelerate trial execution. The strongest market participants will combine operational precision with quality governance, sustainability, regulatory readiness, and data-driven decision-making.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Service

  • 7.1. Investigational Drug Packaging
  • 7.2. Drug Labeling Services
  • 7.3. Comparator Drug Sourcing
  • 7.4. Drug Storage & Distribution
  • 7.5. Cold Chain Drug Transportation
  • 7.6. Depot Management
  • 7.7. Returns & Reconciliation

8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase

  • 8.1. Phase I
  • 8.2. Phase II
  • 8.3. Phase III
  • 8.4. Phase IV

9. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Transportation Mode

  • 9.1. Air Freight
    • 9.1.1. Charter
    • 9.1.2. Standard
  • 9.2. Rail Freight
    • 9.2.1. Direct
    • 9.2.2. Intermodal
  • 9.3. Road Freight
  • 9.4. Sea Freight

10. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Temperature Range

  • 10.1. Ambient
  • 10.2. Controlled Room
  • 10.3. Frozen
  • 10.4. Refrigerated

11. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Packaging Type

  • 11.1. Active Packaging
    • 11.1.1. Cryogenic Shippers
    • 11.1.2. Refrigeration Units
  • 11.2. Hybrid Packaging
    • 11.2.1. Combined Solutions
    • 11.2.2. Modular Systems
  • 11.3. Passive Packaging
    • 11.3.1. Insulated Boxes
    • 11.3.2. Thermal Wraps

12. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Molecule Type

  • 12.1. Small Molecule Drugs
  • 12.2. Biopharmaceutical Drugs

13. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Application

  • 13.1. Oncology
  • 13.2. Neurology
  • 13.3. Cardiology
  • 13.4. Infectious Diseases
  • 13.5. Metabolic Disorders
  • 13.6. Respiratory Disorders

14. Clinical Trial Supply & Logistics for Pharmaceutical Market, by End User

  • 14.1. Biotechnology Companies
  • 14.2. Clinical Trial Sites
  • 14.3. Contract Research Organizations
  • 14.4. Pharmaceutical Companies
  • 14.5. Third-Party Logistics Providers

15. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. North America
  • 15.3. Latin America
  • 15.4. Europe
  • 15.5. Middle East
  • 15.6. Africa

16. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Aenova Group GmbH
  • 19.2. Almac Group
  • 19.3. AmerisourceBergen Corporation
  • 19.4. Bilcare Limited
  • 19.5. Biocair International Limited
  • 19.6. Catalent, Inc.
  • 19.7. Clinigen Group PLC
  • 19.8. DHL International GmbH by Deutsche Post AG
  • 19.9. Eurofins Scientific SE
  • 19.10. FedEx Corporation
  • 19.11. GBA Group AG
  • 19.12. ICON PLC
  • 19.13. Infosys Limited
  • 19.14. KLIFO A/S
  • 19.15. Lonza Group
  • 19.16. Metrics Contract Services by Mayne Pharma group
  • 19.17. Movianto
  • 19.18. Nuvisan GmbH
  • 19.19. Parexel International Corporation
  • 19.20. PCI Pharma Services
  • 19.21. Pharm-Olam International Ltd.
  • 19.22. Seveillar Clinical Trial Supplies Pvt. Ltd.
  • 19.23. SIRO Clinpharm Private Limited
  • 19.24. Thermo Fisher Scientific, Inc.
  • 19.25. UDG Healthcare PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INVESTIGATIONAL DRUG PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INVESTIGATIONAL DRUG PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INVESTIGATIONAL DRUG PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DRUG LABELING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DRUG LABELING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DRUG LABELING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPARATOR DRUG SOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COMPARATOR DRUG SOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPARATOR DRUG SOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DRUG STORAGE & DISTRIBUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DRUG STORAGE & DISTRIBUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DRUG STORAGE & DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLD CHAIN DRUG TRANSPORTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COLD CHAIN DRUG TRANSPORTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLD CHAIN DRUG TRANSPORTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DEPOT MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DEPOT MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DEPOT MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RETURNS & RECONCILIATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RETURNS & RECONCILIATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RETURNS & RECONCILIATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHASE I MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHASE I MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHASE I MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHASE II MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHASE II MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHASE II MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHASE III MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHASE III MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHASE III MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHASE IV MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHASE IV MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHASE IV MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AIR FREIGHT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AIR FREIGHT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AIR FREIGHT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CHARTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CHARTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CHARTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STANDARD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STANDARD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STANDARD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RAIL FREIGHT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RAIL FREIGHT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RAIL FREIGHT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIRECT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIRECT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIRECT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTERMODAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTERMODAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTERMODAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ROAD FREIGHT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROAD FREIGHT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ROAD FREIGHT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SEA FREIGHT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SEA FREIGHT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SEA FREIGHT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AMBIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AMBIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AMBIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONTROLLED ROOM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONTROLLED ROOM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CONTROLLED ROOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FROZEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REFRIGERATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REFRIGERATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL REFRIGERATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ACTIVE PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ACTIVE PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ACTIVE PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CRYOGENIC SHIPPERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CRYOGENIC SHIPPERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CRYOGENIC SHIPPERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL REFRIGERATION UNITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL REFRIGERATION UNITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL REFRIGERATION UNITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HYBRID PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HYBRID PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HYBRID PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL COMBINED SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMBINED SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL COMBINED SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MODULAR SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MODULAR SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MODULAR SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PASSIVE PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PASSIVE PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PASSIVE PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INSULATED BOXES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INSULATED BOXES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INSULATED BOXES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL THERMAL WRAPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL THERMAL WRAPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL THERMAL WRAPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPHARMACEUTICAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOPHARMACEUTICAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPHARMACEUTICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CLINICAL TRIAL SITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CLINICAL TRIAL SITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CLINICAL TRIAL SITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL THIRD-PARTY LOGISTICS PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL THIRD-PARTY LOGISTICS PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL THIRD-PARTY LOGISTICS PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 248. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 249. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 250. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 251. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 252. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 254. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 255. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 256. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. GCC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 289. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 290. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 291. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 292. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 293. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 294. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 296. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 297. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 298. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. G7 CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 303. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 304. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 306. NATO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARM